Lodoxamide Tromethamine Patent Expiration

Lodoxamide Tromethamine is Used for treating ocular allergic responses in human eyes. It was first introduced by Novartis Pharmaceuticals Corp in its drug Alomide on Sep 23, 1993.


Lodoxamide Tromethamine Patents

Given below is the list of patents protecting Lodoxamide Tromethamine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Alomide US5457126 Use of lodoxamide to treat ophthalmic allergic conditions Oct 10, 2012

(Expired)

Novartis



Lodoxamide Tromethamine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List